FAQs
Show All
When was the company founded?
AC Immune was founded in 2003 in Lausanne, Switzerland.
Where is the company incorporated?
We are incorporated under the laws of Switzerland (Confederation Helvetica).
When did AC Immune go public?
AC Immune went public in September 2016.
When is AC Immune’s fiscal year-end?
Our fiscal year ends on December 31. Our fiscal quarters end on March 31, June 30, September 30 and December 31.
On what stock exchange is AC Immune’s stock traded?
Our common stock is listed on the NASDAQ Stock Exchange under the ticker symbol ACIU.
Who are AC Immune’s independent auditors?
PricewaterhouseCoopers SA
Who is AC Immune’s legal counsel?
Switzerland General Corporate matters: Bär & Karrer
US SEC matters: Davis Polk Wardwell
Who is AC Immune’s depository bank?
It is BNY Mellon. Please find the contact details below:

Telephone Queries:
BNY Mellon’s DR Broker Solutions Desk
London: +44 207 163 7427
New York: +1 212 815 2267

Mail Queries:
Regular mail:
BNY Mellon
PO Box 505000
Louisville, KY 40233-5000

Overnight/certified/registered delivery:
BNY Mellon
462 South 4th Street, Suite 1600
Louisville, KY 40202
Where can I get the latest corporate news releases and financial reports?
AC Immune’s press releases can be viewed at:
https://ir.acimmune.com/news

Our financial reports are available at:
https://ir.acimmune.com/sec-filings